Larvol Delta - Association-between-screening-duration-and-treatment-outcomes-in-the-clinical-trials-of-ranibizumab-and-aflibercept-for-neovascular-agerelated-macular-degeneration

Byooviz (ranibizumab-nuna) - Samsung, AffaMed Therap, Biogen, Harrow Health

Yesafili (aflibercept-jbvf) - Biocon

Lucentis (ranibizumab) - Roche, Novartis

http://www.ncbi.nlm.nih.gov/pubmed/41927600

Hyeong Min Kim; Se Joon Woo

Apr 3, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next